<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045355"><TermName>alendronate sodium</TermName><TermPronunciation>(uh-LEN-droh-nayt SOH-dee-um)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat certain bone conditions, such as osteoporosis and Paget disease of the bone. It is also being studied in the treatment of hypercalcemia (high levels of calcium in the blood) and bone pain caused by cancer. Alendronate sodium slows the breakdown of bone and prevents the loss of calcium. It is a type of bisphosphonate. Also called Fosamax.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000705364" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;alendronate sodium&quot;" language="en" id="_3"/><MediaLink ref="CDR0000705365" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;alendronato sódico&quot;" language="es" id="_4"/><SpanishTermName>alendronato sódico</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento usado para tratar ciertas afecciones óseas, como la osteoporosis y la enfermedad de Paget. Asimismo, está en estudio para el tratamiento de la hipercalcemia (concentraciones altas de calcio en la sangre) y el dolor de huesos causado por el cáncer. El alendronato sódico demora el deterioro del hueso y previene la pérdida del calcio. Es un tipo de bisfosfonato. También se llama Fosamax.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2008-01-09</DateLastModified></GlossaryTerm>
